KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Castle Biosciences (CSTL) Cash from Investing Activities (2018 - 2026)

Castle Biosciences' Cash from Investing Activities history spans 8 years, with the latest figure at $8.8 million for Q4 2025.

  • On a quarterly basis, Cash from Investing Activities rose 53.05% to $8.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$60.4 million, a 20.4% decrease, with the full-year FY2025 number at -$60.4 million, down 20.4% from a year prior.
  • Cash from Investing Activities hit $8.8 million in Q4 2025 for Castle Biosciences, up from -$18.4 million in the prior quarter.
  • Over the last five years, Cash from Investing Activities for CSTL hit a ceiling of $16.6 million in Q1 2023 and a floor of -$134.2 million in Q3 2022.
  • Historically, Cash from Investing Activities has averaged -$18.0 million across 5 years, with a median of -$15.1 million in 2023.
  • Biggest five-year swings in Cash from Investing Activities: plummeted 14434.13% in 2022 and later soared 4225.37% in 2023.
  • Tracing CSTL's Cash from Investing Activities over 5 years: stood at -$30.9 million in 2021, then surged by 85.49% to -$4.5 million in 2022, then tumbled by 71.17% to -$7.7 million in 2023, then surged by 175.21% to $5.8 million in 2024, then soared by 53.05% to $8.8 million in 2025.
  • Business Quant data shows Cash from Investing Activities for CSTL at $8.8 million in Q4 2025, -$18.4 million in Q3 2025, and -$28.4 million in Q2 2025.